Taltz Tops Tremfya In Head-To-Head Psoriasis Study On Complete Skin Clearance – Scrip

0
18

Taltz Tops Tremfya In Head-To-Head Psoriasis Study On Complete Skin Clearance  Scrip

Lilly’s IL-17A inhibitor ixekizumab outperformed J&J’s IL-23 inhibitor guselkumab on achieving complete skin clearance in moderate-to-severe psoriasis patients …

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here